Jean Bousquet
Jean Bousquet
Email verificata su
Citata da
Citata da
Allergic rhinitis and its impact on asthma (ARIA) 2008
J Bousquet, N Khaltaev, AA Cruz, J Denburg, WJ Fokkens, A Togias, ...
Allergy 63, 8-160, 2008
Global strategy for asthma management and prevention: GINA executive summary
ED Bateman, SS Hurd, PJ Barnes, J Bousquet, JM Drazen, M FitzGerald, ...
European Respiratory Journal 31 (1), 143-178, 2008
Eosinophilic inflammation in asthma
J Bousquet, P Chanez, JY Lacoste, G Barnéon, N Ghavanian, I Enander, ...
New England Journal of Medicine 323 (15), 1033-1039, 1990
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision
JL Brożek, J Bousquet, CE Baena-Cagnani, S Bonini, GW Canonica, ...
Journal of Allergy and Clinical Immunology 126 (3), 466-476, 2010
Asthma: from bronchoconstriction to airways inflammation and remodeling
J Bousquet, PK Jeffery, WW Busse, M Johnson, AM Vignola
American journal of respiratory and critical care medicine 161 (5), 1720-1745, 2000
A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force
SGO Johansson, JOB Hourihane, J Bousquet, C Bruijnzeel‐Koomen, ...
Allergy 56 (9), 813-824, 2001
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study
ED Bateman, HA Boushey, J Bousquet, WW Busse, TJH Clark, ...
American journal of respiratory and critical care medicine 170 (8), 836-844, 2004
Allergy and allergic diseases
AB Kay
New England Journal of Medicine 344 (1), 30-37, 2001
Allergen immunotherapy: therapeutic vaccines for allergic diseases A WHO position paper
J Bousquet, R Lockey, HJ Malling
Journal of Allergy and Clinical Immunology 102 (4), 558-562, 1998
Dust mite allergens and asthma: report of a second international workshop
TAE Platts-Mills
Journal of Allergy and Clinical Immunology 89 (5), 1046-1060, 1992
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment …
M Humbert, R Beasley, J Ayres, R Slavin, J Hebert, J Bousquet, KM Beeh, ...
Allergy 60 (3), 309-316, 2005
Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach
AA Cruz
World Health Organization, 2007
Induction of nitric oxide synthase in asthma
Q Hamid, DR Springall, JM Polak, V Riveros-Moreno, P Chanez, ...
The Lancet 342 (8886-8887), 1510-1513, 1993
Consensus statement on the treatment of allergic rhinitis
P Van Cauwenberge, C Bachert, G Passalacqua, J Bousquet, ...
Allergy 55 (2), 116-134, 2000
Chronic rhinosinusitis in Europe – an underestimated disease. A GA2LEN study
D Hastan, WJ Fokkens, C Bachert, RB Newson, J Bislimovska, ...
Allergy 66 (9), 1216-1223, 2011
Identifying ‘well-controlled’and ‘not well-controlled’asthma using the Asthma Control Questionnaire
EF Juniper, J Bousquet, L Abetz, ED Bateman, Goal Committee
Respiratory medicine 100 (4), 616-621, 2006
WHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases
J Bousquet
Allergy 53 (44), 1-42, 1998
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma
J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ...
Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010
Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 1 of 3. An overview of the GRADE approach and grading quality of evidence …
JL Brożek, EA Akl, P Alonso‐Coello, D Lang, R Jaeschke, JW Williams, ...
Allergy 64 (5), 669-677, 2009
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children
A Des Roches, L Paradis, JL Menardo, S Bouges, JP Daurés, J Bousquet
Journal of allergy and clinical immunology 99 (4), 450-453, 1997
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20